Roivant Sciences President, Immunovant CEO Eric Venker disposes of common shares worth $7.15 million - ROIV News | RalliesRoivant Sciences President, Immunovant CEO Eric Venker disposes of common shares worth $7.15 million
R
ROIV• Eric Venker cuts Roivant stake after share sales and option exercise
- Roivant Sciences President and Immunovant CEO Eric Venker cut his stake to 1,599,154 common shares on Aug. 28, 2026.
- He disposed of 200,000 shares at prices of USD 35.63 and USD 36.44.
- He also exercised stock options for 200,000 shares at USD 3.85.
•
